GlassScriptPhysician profile
Gregory R Jackson
NPI 1518284843
$3,770.41
in general payments reported to CMS, 2019-2025
9 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.48 · 2021: $2,548 · 2022: $19.44 · 2023: $324 · 2024: $277 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $2,500.00 | 2021 | |
| Cvrx, INC. | $303.55 | 2023-2025 | Barostim Neo System |
| Abiomed | $272.56 | 2023-2025 | Impella |
| Endotronix, INC. | $270.75 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Abbott Laboratories | $214.11 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $155.13 | 2023-2024 | Reveal Linq |
| Itamar Medical INC | $29.62 | 2024 | Watchpatone |
| Briohealth Solutions, INC. | $24.69 | 2025 | Briovad |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.